Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2
Granton, J., Bergot, E., Boonstra, A., Subias, P.E., Galiè, N., Langleben, D., Lemarié, J.C., Pfister, T., Simonneau, G., Sitbon, O., Delcroix, M.Том:
35
Мова:
english
Журнал:
The Journal of Heart and Lung Transplantation
DOI:
10.1016/j.healun.2016.01.1031
Date:
April, 2016
Файл:
PDF, 144 KB
english, 2016